A new qualitative study by researchers at Columbia University Mailman School of Public Health found that the majority of women living with HIV would endorse a monthly long acting injectable (LAI) antiretroviral therapy over ...
Apr 22, 2020
0
2
Nearly half of people in the U.S. diagnosed with HIV, the virus that causes AIDS, are over 50, according to the Centers for Disease Control and Prevention (CDC). HIV damages the body's immune system, and interferes with the ...
Apr 13, 2020
0
8
(HealthDay)—Amongpatients with multidrug-resistant HIV-1 infection who have limited therapy options, reductions in HIV-1 RNA level were significantly greater in those who received fostemsavir compared with placebo during ...
Mar 26, 2020
0
103
Stimulating immune cells with two cancer immunotherapies together can shrink the size of the viral "reservoir" in SIV-infected non-human primates treated with antiviral drugs, researchers have concluded. The reservoir includes ...
Mar 16, 2020
0
74
As my governor closes all the public schools and public libraries here in Seattle, I'm thinking about 1981—the year when newspapers in New York and Los Angeles reported that a strange new virus was killing healthy young ...
Mar 16, 2020
1
1
In parts of Africa, where the rate of HIV is high, researchers found that using mobile vans to dispense antiretroviral treatment and other care greatly increased viral suppression.
Mar 9, 2020
0
1
For people living with HIV, any level of alcohol consumption is associated with lower levels of a protein involved in bone formation, raising the risk of osteoporosis, according to a new study by researchers from the Boston ...
Mar 3, 2020
0
2
HIV and AIDS are still global health problems and sub-Saharan Africa remains the most affected region. Globally, around 770,000 people died from AIDS-related conditions in 2018, 160,000 of them in West and Central Africa.
Feb 12, 2020
0
1
The major obstacle to curing HIV is a vast reservoir of "latent, replication-competent proviruses," which have infiltrated the very cells that help orchestrate the immune response.
Adding maraviroc to standard combined antiretroviral therapy (c-ART) does not seem to improve clinical outcomes for patients initiating treatment for advanced HIV infection. Findings from a double-blind randomized controlled ...
Feb 11, 2020
0
2
